ArticleCell death discovery2022

MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling.

Xin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.